Since VEGF acts in the near vicinity (within 0.5 mm) of its release, measuring local secretion of VEGF and sVEGFR-2 in urine might be useful biomarkers for identifying those HFRS patients who will progress to severe disease, but it requires further study. The gene discussed is VEGFA; the disease is hemorrhagic fever with renal syndrome.